Lamin A/C deficiency as a cause of familial dilated cardiomyopathy

Rohit Malhotra1, Pamela K Mason

  • 1University of Virginia Health System, Charlottesville, Virginia 22908-0158, USA.

Insights

Lamin A/C deficiency is a significant cause of familial dilated cardiomyopathy. Patients face a poor prognosis, necessitating high clinical suspicion for diagnosis and aggressive management.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Familial dilated cardiomyopathy is often caused by Lamin A/C deficiency.
  • Emerging research highlights the significance of Lamin A/C deficiency in genetic heart conditions.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and treatment of Lamin A/C deficiency.
  • To explore disease mechanisms and current knowledge gaps.

Main Methods:

  • Review of current literature on Lamin A/C deficiency.
  • Analysis of screening data for dilated cardiomyopathy patients.
  • Examination of findings from animal models.

Main Results:

  • Lamin A/C deficiency is a key genetic cause of dilated cardiomyopathy.
  • Novel mutations are frequently identified, often family-specific.
  • Lamin A/C insufficiency can lead to apoptosis, particularly in the cardiac conduction system.
  • The disease course is often malignant, with risks of heart failure and sudden cardiac death.

Conclusions:

  • A high index of suspicion is crucial for diagnosing Lamin A/C deficiency.
  • Understanding of disease mechanisms, diagnosis, and treatment remains incomplete.
  • Aggressive monitoring is essential for affected individuals due to the poor prognosis.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...